Ainos, Inc. is a dual-platform AI and biotech company advancing SmellTech and immune therapeutics. Its AI Nose platform and smell language model (SML) digitize scent into Smell ID, a machine-readable data, powering applications across robotics, smart factories, and healthcare. It is also developing VELDONA, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health. Its pipeline includes drug candidates for treating oral warts for human immunodeficiency virus seropositive patients, Sjogren’s syndrome, and feline chronic gingivostomatitis, a cat oral infection. Its product pipeline includes VELDONA Pet, VELDONA human drugs, AI Nose - NISD co-development, AI Nose industrial and robotics application, VOC POCT, VOC POCT Ainos Pen, VOC POCT CHS430, and Synthetic RNA (SRNA). VOC POCT-Ainos Pen is a device intended to be a cloud-connected, multipurpose, portable breath analyzer that is intended to monitor health conditions.
Símbolo de cotizaciónAIMD
Nombre de la empresaAinos Inc
Fecha de salida a bolsaAug 08, 1996
Director ejecutivoTsai (Chun-Hsien)
Número de empleados44
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 08
Dirección8880 Rio San Diego Drive, Ste. 800
CiudadSAN DIEGO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal92108
Teléfono18588692986
Sitio Webhttps://www.ainos.com/
Símbolo de cotizaciónAIMD
Fecha de salida a bolsaAug 08, 1996
Director ejecutivoTsai (Chun-Hsien)
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos